Presynaptic Regulation by ACh of the NE Mediated Responses in the Rat Vas Deferens

References

• Minneman K. P., Fox A. W., Abel P. W. Occupancy of alpha1-adrenergic, receptors and contraction of rat vas deferens. Mol. Pharmacol. 1983; 23: 359
   PubMedGoogle Scholar
• Drew G. M. Pharmacological characterization of the presynaptic α-adrenoceptor in the rat vas deferens. Eur. J. Pharmacol. 1977; 42: 123
   PubMed Web of Science ®Google Scholar
• Lotti J., Kling P, Cerino D. High and low (Gpp(NH) p-sensitive) affinity sites for β2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferens. Eur. J. Pharmacol. 1982; 84: 161
   Google Scholar
• Doxey J. C., Roach A. G. Presynaptic α-adrenoceptors: In vitro methods and preparation utilized in the evaluation of agonists and antagonists. J. Autonom. Pharmacol. 1980; 1: 73
   Google Scholar
• Bustos E., Miranda H., Paeile C. Cholinergic transmission in vas deferens. Gen. Pharmacol. 1983; 14: 693
   Google Scholar
• Simon A., Van Maanen E. F. Dopamine receptors and dopaminergic nerves in the vas deferens of the rats. Archs. int. Pharmacodyn. Thér. 1976; 222: 4
   Google Scholar
• Lemaire S., Magnan J., Regoli D. Rat vas deferens a specific bicassay for endogenous opioid peptides. Br. J. Pharmacol. 1978; 64: 327
   PubMedGoogle Scholar
• Miranda H., Huidobro F., Toro J. P. Evidence for morphine and morphine-like alkaloid responses resistant to naloxone blackade in the rat vas deferens. Life Sci. 1979; 24: 1511
   Google Scholar
• Miranda H., Rosselot F., Vergara J., Fernández E., Larraín G. Biogenic amines and morphine responses in the rat vas deferens. Gca. Pharmacol. 1981; 12: 331
   Google Scholar
• Miranda H., Vergara J. F., Rosselot F., Fernández E. Biogenic amines and β-endorphin responses in the rat vas deferens. Gen. Pharmacol. 1982; 13: 45
   Google Scholar
• Wuster M., Schulz R., Herz A. The direction of opioid agonists towards, μ-,δ-and ±-receptors in the vas deferens of the mouse and the rat. Life Sci. 1980; 27: 163
   PubMed Web of Science ®Google Scholar
• Henderson G., Hughes J., Kosterlitz H. W. A new example of a morphine-sensitive neuroeffector junction: adrenergic transmission in the mouse vas deferens. Br. J. Pharmacol. 1972; 46: 764
   PubMed Web of Science ®Google Scholar
• Richelson E., El-Fakahany E. The molecular basis of neurotransmission at the muscarinic receptor. Biochem. Pharmacol. 1981; 30: 2887
   PubMed Web of Science ®Google Scholar
• SzerbIn I. C. Cholinergic Mechanism and Psychopharmacology, D. J. Jenden. Plenum Press, New York 1977; 49–60
   Google Scholar
• Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 1980; 32: 337
   PubMed Web of Science ®Google Scholar
• Starke K. Regulation of noradrenaline release by presynaptic receptor system. Rev. Physiol. Biochem. Pharmacol. 1977; 77
   Google Scholar
• Westfall T. C. Evidence that noradrenergic transmitter release is regulated by presynaptic receptors. Fed. Proc. 1984; 43: 1352
   Google Scholar
• List S., Titeler M., Seeman P. High-affinity 3H-do- pamine receptors (D3 sites) in human and rat brain. Biochem. Pharmacol. 1980; 29: 1621
   Google Scholar
• Sokoloff P., Martress M. P., Schwartz J. C. 3H-apromorphine labels both dopamine postsynaptic receptors and autoreceptors. Nature 1980; 288: 283
   Google Scholar
• Creese I., Sibley D. R., Leff S. Classification of dopamine receptors. Adv. Biochem. Psychopharmacol. 1983; 37: 255
   Google Scholar
• Burnstoack G. Autonomic innervation and transmission. Br. Med. Bull. 1979; 35: 255
   Google Scholar
• Fredholm B. B., Hedqvist P. Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem. Pharmacol. 1980; 29: 1635
   PubMed Web of Science ®Google Scholar
• Daly J. W., Burns R. F., Snyder S. H. Adenosine receptors in the central nervous system : relationship to the central actions of methylxanthines. Life Sci. 1981; 28: 2083
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Moret C., Raisman R., Dubocovich M. L., Briley M. High-affinity [3H] imipramine binding in rat hyprothalamus: association with uptake of serotonin but not of norepinephrine. Science 1980; 210: 1133
   PubMed Web of Science ®Google Scholar
• Paul S. M., Rehavi M., Rice K. C., Ittah Y., Skolnick P. Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelete. Life Sci. 1981; 28: 2753
   PubMed Web of Science ®Google Scholar
• Krogsgaard-Larse P., Falch E., Peet M. J., Leag J. D., Curtis D. R. Molecular pharmacology of the GABA receptors and GABA agonists. Adv. Biochem. Psychopharmacol. 1983; 37: 1
   Google Scholar
• McBean G. J., Roberts P. J. Glutamate-perfusing receptors regulate the release of D-[3H] aspartate from rat hippocampal slices. Nature 1981; 291: 593
   Google Scholar
• Abbs E. T., Joseph D. N. The effects of atropine and oxotremorine on acetylcholine release in rat phrenic nervediaphragm preparations. Br. J. Pharmacol. 1981; 73: 481
   Google Scholar
• Yamado S., Hayashi E., Yamamura H. I., Roeske W. R. Presynaptic muscarinic cholinergic and post-synaptic β-adrenergic receptors in splenic tissue. Adv. Biochem. Psychopharmacol. 1983; 36: 43
   Google Scholar
• Sharma V. K., Banergee S. P. Presynaptic muscarinic cholinergic receptors. Nature (Lond.) 1978; 272: 776
   Google Scholar
• Vanhoutte P. M., Levy M. N. Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. Am. J. Physiol. 1980; 238: 275
   PubMedGoogle Scholar
• Vizi E. S. Presynaptic modulation of neurochemical transmission. Fed. Proc. 1977; 36: 2444
   Google Scholar
• Lehmann J., Langer S. Z. Muscarinic receptors on dopamine terminals in the cat candate nucleus: neuromodulation of [3H] dopamine release in vitro by endogenous acetylcholine. Brain, Res. 1982; 248: 61
   Google Scholar
• Raiteri M., Marchi U., Maura G. Presynaptic muscarinic receptors increase striated dopamine release evoked by ‘quasi-physiological’ depolarization. Eur. J. Pharmacol. 1982; 83: 127
   Google Scholar
• Miranda H. Vas deferens desensitization by noradrenaline and other drugs. Archs. int. Pharmacodyn. Thér. 1976; 221: 223
   Google Scholar
• Gillespie J., McGrath J. C. The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat enococcygeus muscle and vas deferens. Br. J. Pharmacol. 1974; 52: 585
   Google Scholar
• French A. M., Scott N. C. Evidence to support the hypothesis that ATP is a co-transmitter in rat vas deferens. Experientia. 1983; 39: 264
   PubMedGoogle Scholar
• Liao C. S., Freer R. J. Acetylcholine potentiation of field stimulated rat vas deferens: a pre-synaptic muscarinic mechanism?. Life Sci. 1983; 33: 1861
   Google Scholar
• Lindmar R., Loffeholz K., Muscholl E. A. Muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibers by nicotinic agents. Br. J. Pharmacol. 1968; 32: 279
   Google Scholar
• Nathanson J. A. Cyclic nucleotides and nervous system function. Physiol. Rev. 1977; 57: 157
   PubMed Web of Science ®Google Scholar
• Fredholm B. B., Sandberg G. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3′,5′-monophosphate accumulation in rat and guinea-pig thymocytes. Br. J. Pharmacol. 1983; 80: 639
   Google Scholar
• Finber J. P.M., Buccafusco J. J., Spector S. Regional brain acetylcholine kinetics effects of reserpine. Life Sci. 1979; 25: 147
   Google Scholar
• Shibata S., Kuchii M., Kurahashi K. The supersensitivity of isolated rabbit atria and aortic strips produced by 6-hydroxydopamine. Eur. J. Pharmacol. 1972; 18: 271
   Google Scholar
• Nomura Y., Kajiyama H., Segawa T. Possible influence of noradrenaline on β-adrenergic and muscarinic cholinergic receptors in rat heart: effects of 6-hydroxydopa, isoproterenol, and desmethylimipramine. Adv. Biochem. Psychopharmacol. 1983; 36: 83
   Google Scholar
• Burn J. H., Rand M. J. The cause of the supersensitivity of smooth muscle to noradrenaline after sympathetic degeneration. J. Physiol. 1959; 147: 135
   PubMed Web of Science ®Google Scholar
• Haeusler G., Haefely W. D., Thoenen H. J. Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 1969; 170: 60
   Google Scholar
• Nadeau R., De Champlain J., Tremblay D. M. Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine. Can. J. Physiol. Pharmacol. 1971; 49: 36
   PubMed Web of Science ®Google Scholar